Oxidant-antioxidant balance in the blood of patients with chronic obstructive pulmonary disease after smoking cessation

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Woźniak, Alina ^a   Górecki, Dariusz ^b   Szpinda, Michał ^a   Mila Kierzenkowska, Celestyna ^a   Woźniak, Bartosz ^c  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Specialist Family Medicine Center   (Poland)

^c Stanislaw Staszic Specialist Hospital   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE PULMONARY DISEASE; CONJUGATED DIENES; GLUTATHIONE PEROXIDASE; SMOKING CESSATIONS; SPIROMETRIC PARAMETERS; STUDY GROUPS; SUPEROXIDE DISMUTASE ACTIVITIES; THIOBARBITURIC ACID-REACTIVE SUBSTANCES;

ANTIOXIDANTS; BLOOD; OXIDANTS; OXYGEN;

PULMONARY DISEASES;

ALKADIENE; ALPHA TOCOPHEROL; ANTIOXIDANT; CATALASE; GLUTATHIONE PEROXIDASE; OXIDIZING AGENT; RETINOL; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; BIOLOGICAL MARKER; VITAMIN;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; SMOKING; SMOKING CESSATION; SPIROMETRY; BLOOD; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; STATISTICS;

ADULT; AGED; ANTIOXIDANTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDANTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING CESSATION; SPIROMETRY; STATISTICS AS TOPIC; VITAMINS;

EID: 84884822194     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/897075     Document Type: Article

References (44)

1. Devereux G., ABC of chronic obstructive pulmonary disease: definition, epidemiology, and risk factors. British Medical Journal 2006 332 7550 1142 1144 2-s2.0-33646845814 (Pubitemid 44480883)
2. Panzner P., Cytokines in chronic obstructive pulmonary disease and chronic bronchitis. Alergia Astma Immunologia 2002 8 2 91 99 2-s2.0-0036352006 (Pubitemid 34951359)
3. Barnes P. J., Shapiro S. D., Pauwels R. A., Chronic obstructive pulmonary disease: molecular and cellular mechanisms. European Respiratory Journal 2003 22 4 672 688 2-s2.0-0141928029 (Pubitemid 37258549)
4. Wada H., Takizawa H., Future treatment for COPD: targeting oxidative stress and its related signal. Recent Patents on Inflammation & Allergy Drug Discovery 2013 7 1 1 11
5. Tam A., Sin D. D., Pathobiologic mechanisms of chronic obstructive pulmonary disease. The Medical Clinics of North America 2012 96 4 681 698 10.1016/j.mcna.2012.04.012
6. Miglino N., Roth M., Tamm M., Borger P., Asthma and COPD-the C/EBP connection. The Open Respiratory Medicine Journal 2012 6 1 13
7. MacNee W., Rahman I., Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease? Trends in Molecular Medicine 2000 7 2 55 62 2-s2.0-0034474704 10.1016/S1471-4914(01)01912-8 (Pubitemid 32194683)
8. Mateos F., Brock J. H., Pérez-Arellano J. L., Iron metabolism in the lower respiratory tract. Thorax 1998 53 7 594 600 2-s2.0-0031866706 (Pubitemid 28335522)
9. Rahman I., Skwarska E., MacNee W., Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease. Thorax 1997 52 6 565 568 2-s2.0-0030754025 (Pubitemid 27298512)
10. Komaki Y., Sugiura H., Koarai A., Tomaki M., Ogawa H., Akita T., Hattori T., Ichinose M., Cytokine-mediated xanthine oxidase upregulation in chronic obstructive pulmonary disease's airways. Pulmonary Pharmacology and Therapeutics 2005 18 4 297 302 2-s2.0-15244354175 10.1016/j.pupt.2005.01.002 (Pubitemid 40385064)
11. Richter C., Gogvadze V., Laffranchi R., Schlapbach R., Schweizer M., Suter M., Walter P., Yaffee M., Oxidants in mitochondria: from physiology to diseases. Biochimica et Biophysica Acta 1995 1271 1 67 74 2-s2.0-0029071509 10.1016/0925-4439(95)00012-S
12. Pratt D. A., Tallman K. A., Porter N. A., Free radical oxidation of polyunsaturated lipids: new mechanistic insights and the development of peroxyl radical clocks. Accounts of Chemical Research 2011 44 6 458 467 2-s2.0-79959460547 10.1021/ar200024c
13. Favier A., The oxidative stress: Interest of its monitoring in clinical chemistry and problems of the choice of an appropriate parameter. Annales de Biologie Clinique 1997 55 1 9 16 2-s2.0-0031020452 (Pubitemid 27087040)
14. Woźniak A., Signs of oxidative stress after exercise. Biology of Sport 2003 20 2 93 112 2-s2.0-0037626396 (Pubitemid 36836329)
15. Michel F., Bonnefont-Rousselot D., Mas E., Drai J., Thérond P., Biomarkers of lipid peroxidation: analytical aspects. Annales de Biologie Clinique 2008 66 6 605 620 2-s2.0-58149378513 10.1684/abc.2008.0283
16. Cantin A. M., Cellular response to cigarette smoke and oxidants: adapting to survive. Proceedings of the American Thoracic Society 2010 7 6 368 375 2-s2.0-79952670311
17. Mak J. C. W., Pathogenesis of COPD. Part II. Oxidative-antioxidative imbalance. International Journal of Tuberculosis and Lung Disease 2008 12 4 368 374 2-s2.0-41949123520 (Pubitemid 351507247)
18. Hasnain B. I., Mooradian A. D., Recent trials of antioxidant therapy: what should we be telling our patients? Cleveland Clinic Journal of Medicine 2004 71 4 327 334 2-s2.0-4444333965 (Pubitemid 38499735)
19. Scanlon P. D., Connett J. E., Waller L. A., Altose M. D., Bailey W. C., Buist A. S., Tashkin D. P., Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: the lung health study. American Journal of Respiratory and Critical Care Medicine 2000 161 2 I 381 390 2-s2.0-0034063821 (Pubitemid 30129442)
20. Sergent O., Morel I., Cogrel P., Chevanne M., Pasdeloup N., Brissot P., Lescoat G., Cillard P., Cillard J., Simultaneous measurements of conjugated dienes and free malondialdehyde, used as a micromethod for the evaluation of lipid peroxidation in rat hepatocyte cultures. Chemistry and Physics of Lipids 1993 65 2 133 139 2-s2.0-0027292908 10.1016/0009-3084(93)90046-6 (Pubitemid 23213487)
21. Buege J. A., Aust S. D., Microsomal lipid peroxidation. Methods in Enzymology 1978 52 C 302 310 2-s2.0-0017872475 10.1016/S0076-6879(78)52032-6
22. Esterbauer H., Cheeseman K. H., Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods in Enzymology 1990 186 407 421 2-s2.0-0025127633 10.1016/0076-6879(90)86134-H (Pubitemid 20279982)
23. Misra H. P., Fridovich I., The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. The Journal of Biological Chemistry 1972 247 10 3170 3175 2-s2.0-0015523099
24. Beers R. F. Jr., Sizer I. W., A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. The Journal of biological chemistry 1952 195 1 133 140 2-s2.0-41049100518
25. Paglia D. E., Valentine W. N., Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. The Journal of Laboratory and Clinical Medicine 1967 70 1 158 169 2-s2.0-0014108436
26. Wieliński S., Olszanowski A., Practical optimization of solvent selectivity using gradient elution for rapid selection and mixture-design statistical technique for the separation of fat-soluble vitamins. Journal of Liquid Chromatography and Related Technologies 1999 22 20 3115 3128 2-s2.0-0039021609 10.1081/JLC-100102079 (Pubitemid 129515936)
27. Lee S.-I., The level of antioxidant enzymes in red blood cells of patients with chronic obstructive pulmonary disease. Tuberculosis and Respiratory Diseases 1997 44 1 104 113 2-s2.0-0030970618 (Pubitemid 27272584)
28. De Castro J., Hernández-Hernández A., Rodríguez M. C., Sardina J. L., Llanillo M., Sánchez-Yagüe J., Comparison of changes in erythrocyte and platelet phospholipid and fatty acid composition and protein oxidation in chronic obstructive pulmonary disease and asthma. Platelets 2007 18 1 43 51 2-s2.0-33847053277 10.1080/09537100600800776
29. Cristóvão C., Cristóvão L., Nogueira F., Bicho M., Evaluation of the oxidant and antioxidant balance in the pathogenesis of chronic obstructive pulmonary disease. Revista Portuguesa De Pneumologia 2013 19 2 70 75
30. Folchini F., Nonato N. L., Feofiloff E., D'Almeida V., Nascimento O., Jardim J. R., Association of oxidative stress markers and C-reactive protein with multidimensional indexes in COPD. Chronic Respiratory Disease 2011 8 2 101 108 2-s2.0-79957508680 10.1177/1479972310391284
31. Çalikolu M., Ünlü A., Tamer L., Ercan B., Budayci R., Atik U., The levels of serum vitamin C, malonyldialdehyde and erythrocyte reduced glutathione in chronic obstructive pulmonary disease and in healthy smokers. Clinical Chemistry and Laboratory Medicine 2002 40 10 1028 1031 2-s2.0-0036430983 10.1515/CCLM.2002.179 (Pubitemid 35356021)
32. Santos M. C., Oliveira A. L., Viegas-Crespo A. M., Vicente L., Barreiros A., Monteiro P., Pinheiro T., Bugalho de Almeida A., Systemic markers of the redox balance in chronic obstructive pulmonary disease. Biomarkers 2004 9 6 461 469 2-s2.0-15544378852 10.1080/13547500400024768 (Pubitemid 40403129)
33. Nadeem A., Raj H. G., Chhabra S. K., Increased oxidative stress and altered levels of antioxidants in chronic obstructive pulmonary disease. Inflammation 2005 29 1 23 32 2-s2.0-33644617339 10.1007/s10753-006-8965-3
34. Torres-Ramos Y. D., Montoya-Estrada A., Guzman-Grenfell A. M., Mancilla-Ramirez J., Cardenas-Gonzalez B., Blanco-Jimenez S., Sepulveda-Sanchez J. D., Ramirez-Venegas A., Hicks J. J., Urban PM2.5 induces ROS generation and RBC damage in COPD patients. Frontiers in Bioscience 2011 3 808 817 2-s2.0-80053597368
35. Hanta I., Kocabas A., Canacankatan N., Kuleci S., Seydaoglu G., Oxidant-antioxidant balance in patients with COPD. Lung 2006 184 2 51 55 2-s2.0-33645977165 10.1007/s00408-005-2561-4
36. Waseem S. M. A., Hossain M. M., Islam N., Ahmad Z., Comparative study of pulmonary functions and oxidative stress in smokers and non-smokers. Indian Journal of Physiology and Pharmacology 2012 56 4 345 352
37. Rai R. R., Phadke M. S., Plasma oxidant-antioxidant status in different respiratory disorders. Indian Journal of Clinical Biochemistry 2006 21 2 161 164 2-s2.0-33751058741 10.1007/BF02912934 (Pubitemid 44756945)
38. Zhou J., Guo F., Qian Z., Effects of cigarette smoking on antioxidant vitamin and activities of antioxidases. Zhonghua Yu Fang Yi Xue Za Zhi 1997 31 2 67 70 2-s2.0-0031082688
39. Lin Y.-C., Wu T.-C., Chen P.-Y., Hsieh L.-Y., Yeh S.-L., Comparison of plasma and intake levels of antioxidant nutrients in patients with chronic obstructive pulmonary disease and healthy people in Taiwan: a case-control study. Asia Pacific Journal of Clinical Nutrition 2010 19 3 393 401 2-s2.0-78751514594
40. Jenkins R. R., Krause K., Schofield L. S., Influence of exercise on clearance of oxidant stress products and loosely bound iron. Medicine and Science in Sports and Exercise 1993 25 2 213 217 2-s2.0-0027477394 (Pubitemid 23061982)
41. Sahin Ü., Ünlü M., Özgüner F., Sütcü R., Akkaya A., Delibas N., Lipid peroxidation and glutathione peroxidase activity in chronic obstructive pulmonary disease exacerbation: prognostic value of malondialdehyde. Journal of Basic and Clinical Physiology and Pharmacology 2001 12 1 59 68 2-s2.0-0034972163 (Pubitemid 32565288)
42. Karadag F., Karul A. B., Cildag O., Altun C., Gurgey O., Determinants of BMI in patients with COPD. Respirology 2004 9 1 70 75 2-s2.0-2442528455 10.1111/j.1440-1843.2003.00533.x (Pubitemid 38647773)
43. Louhelainen N., Rytilä P., Haahtela T., Kinnula V. L., Djukanović R., Persistence of oxidant and protease burden in the airways after smoking cessation. BMC Pulmonary Medicine 2009 9, article 25 2-s2.0-67649182964 10.1186/1471-2466-9-25
44. Yang S. C., Relationship between smoking habits and lung function changes with conventional spirometry. Journal of the Formosan Medical Association 1993 92 S225 S231 2-s2.0-0027792937